Nintx and Adeste partner to develop multi-target therapies using raw materials from the Amazon
- Nintx
- Sep 10, 2021
- 1 min read
The partnership is leveraged by a flagship project that has the potential to treat a multifactorial disease (multi-target therapy)
Nintx and Adeste partner to develop multi-target therapies using raw materials from the Amazon. The partnership is leveraged by a flagship project that has the potential to treat a multifactorial disease. “Adeste has access to biodiversity arrangements as well as deep knowledge in extraction technologies and industrial capabilities. We needed a partner like Nintx, with solid experience in early stage, to guide us to the development stage”, said Marcus Kienast, CEO, Adeste. “We view the partnership with Adeste as strategic due to their capacity to manufacture ingredients from natural sources using the industry’s highest standards. We look forward to working together with Adeste to jointly develop multi-target therapies”, stated Dr. Miller Nunes de Freitas, CEO, Nintx.
To have access to the full content, check us out on LinkedIn.
Comments